Paris Biotech Santé

Sep 25, 2017

Exeliom Biosciences joins Paris Biotech Santé Incubator

Mar 4, 2024

Exeliom is awarded a $500k grant from the Crohn's and Colitis Foundation!

Clinical Trial Live Biotherapeutics Crohn's Disease Belgium

Feb 24, 2022

Exeliom Biosciences announces approval of Clinical Trial Application from the Belgian Agency for Single Strain Live Biotherapeutic EXL01 (Faecalibacterium prausnitzii) for the treatment of Crohn’s Disease

Manufacturing

May 7, 2021

Exeliom Biosciences opens pilot manufacturing unit for Live Biotherapeutics (LBPs) thanks to European H2020 Accelerator Program

contact

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.